Semaglutide is the same active ingredient in Wegovy® and Ozempic®. Semaglutide was originally designed to treat type 2 diabetes and has been found to be effective for weight loss.
As a GLP-1 receptor agonist, it helps manage blood sugar while also playing a role in controlling appetite. Recent studies have highlighted its potential in helping individuals with obesity or excess weight achieve significant weight loss. By curbing hunger and enhancing feelings of satiety, semaglutide helps reduce overall calorie consumption.
This makes semaglutide a promising non-surgical option for weight management, especially for those who have struggled with obesity. However, it should always be used under medical supervision, taking into account personal health factors and possible side effects. See Important Safety Risks.
Coby believes in flexibility and transparency. Our pricing structure is designed to ensure there are no hidden fees or surprises in your monthly costs. Coby's compounded semaglutide pricing is as follows:
Kickstart Quarterly Plan: $627 $479
(Save almost 25%!)
Month 1 (0.25mg/week): $159 (weeks 1-4)
Month 2 (0.5 mg/week): $199 (weeks 5-8)
Month 3 (1.0mg/week): $229 (weeks 9-12)
Month 4 (1.7 mg/week): $249 (weeks 13-16)
Month 5+ (2.4mg/week): $269 (weeks 17+)
Kickstart Plan Details: The Kickstart plan is designed to assist patients new to this medication and to help reduce costs of titrating to the correct dosage that best suits their needs. The Kickstart Plan includes the dosage for Month 1 to Month 3 dosage above. Only new patients starting at Month 1 dosage are eligible to participate in this Kickstart Plan.
The dosages listed above are provided for informational purposes only and do not replace professional medical advice. Always consult your physician, who will guide you in determining the appropriate titration schedule and prescribe the necessary medication.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit id venenatis pretium risus euismod dictum egestas orci netus feugiat ut egestas ut sagittis tincidunt phasellus elit etiam cursus orci in. Id sed montes.
Our online visit will guide you through the process to connect with a doctor.
Upon approval, your clinician will provide a personalized treatment plan.
Your GLP-1 weight loss medication will be delivered to your doorstep.
Semaglutide, a GLP-1 receptor agonist is the same active ingredient as brand-name medications. With no-wait consultations and free shipping upon approval, Coby users have the most straightforward experience possible.
At Coby, the initial dose for semaglutide generally starts at 0.25mg per week, subject to approval by your medical provider.
Your provider will gradually increase your Compounded Semaglutide dose to provide the best results and minimize side effects.
At Coby, we strive to provide transparent pricing to make Compounded Semaglutide both affordable and predictable.
Same active ingredient as Mounjaro® and Zepbound®
Choose from monthly (cancel anytime) and quarterly packages
Includes at-home injection kit (alcohol pads and syringes)
Product images are for illustration only. Actual product will vary. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Coby has no affiliation with Eli Lilly. See Important Safety Information.
